You just read:

ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer's Disease

News provided by

ProMIS Neurosciences Inc.

Jun 12, 2018, 07:30 ET